Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
197
datasets available to search
ShareScore release 0.7.1
Dataset results
197 results for “BCMA”
CAR Density Influences Antitumoral Efficacy of BCMA CAR T Cells and Correlates with Clinical Outcome [RNA-seq]
GEO Series GSE197843. Homo sapiens. 24 samples. Type: Expression profiling by high throughput sequencing.
CD4+ T-Cells Mediate CART Immune-Related Adverse Events (CirAE) Following BCMA CART Therapy
GEO Series GSE309403. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with Multiple Myeloma
GEO Series GSE164551. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.
CD4+ CAR-T cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR-T cell therapy II
GEO Series GSE274185. Homo sapiens. 5 samples. Type: Expression profiling by high throughput sequencing.
Identification of molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple Myeloma
GEO Series GSE250444. Homo sapiens. 2 samples. Type: Expression profiling by high throughput sequencing.
scRNAseq Datasets Supporting Tumor Intrinsic Mechanisms of Antigen Escape to Anti-BCMA and Anti-GPRC5D Targeted Immunotherapies in Multiple Myeloma
GEO Series GSE226335. Homo sapiens. 2 samples. Type: Expression profiling by high throughput sequencing.
Tumor Intrinsic Mechanisms of Antigen Escape to Anti-BCMA and Anti-GPRC5D Targeted Immunotherapies in Multiple Myeloma
GEO Series GSE226336. Homo sapiens. 39 samples. Type: Other; Expression profiling by high throughput sequencing.
The B cell maturation antigen (BCMA) is dispensable for long-lived plasma cell survival
GEO Series GSE277098. Mus musculus. 24 samples. Type: Expression profiling by high throughput sequencing.
CAR Density Influences Antitumoral Efficacy of BCMA CAR T Cells and Correlates with Clinical Outcome [scRNA-seq]
GEO Series GSE197848. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Decoding Plasma Cell Maturation Dynamics with BCMA
GEO Series GSE276846. Mus musculus. 16 samples. Type: Expression profiling by high throughput sequencing.
scCNVseq Datasets Supporting Tumor Intrinsic Mechanisms of Antigen Escape to Anti-BCMA and Anti-GPRC5D Targeted Immunotherapies in Multiple Myeloma
GEO Series GSE226327. Homo sapiens. 37 samples. Type: Other.
Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04272151. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.
ClinicalTrials.gov study NCT06733610. IPD Sharing: NO. Countries: 1. Publications: 0.
Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)
ClinicalTrials.gov study NCT07200089. IPD Sharing: YES. Countries: 1. Publications: 0.
Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL
ClinicalTrials.gov study NCT04846439. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases
ClinicalTrials.gov study NCT06787989. IPD Sharing: NO. Countries: 1. Publications: 0.
BCMA-CAR-T in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03664661. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Feasibility and Safety Study of Dual Specificity CD38 and BCMA CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03767751. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05577000. IPD Sharing: NO. Countries: 1. Publications: 0.
Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
ClinicalTrials.gov study NCT07003568. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.